Shield Therapeutics PLC
LSE:STX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Shareholder Yield
Current shareholder yield for 
STX is
.
Dividends, buybacks and debt paydown, as one yield.
Create a free account · No card needed
Create a free account · No card needed
Create a free account · No card needed
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
STX Price
Shield Therapeutics PLC
| Average Annual Return | 9.87% |
| Standard Deviation of Annual Returns | 145.56% |
| Max Drawdown | -97% |
| Market Capitalization | 35.3m GBX |
| Shares Outstanding | 1 074 190 000 |
| Percentage of Shares Shorted |
N/A
|
STX Return Decomposition
Main factors of price return
Stock Splits
STX's latest stock split occurred on Dec 16, 2022
The company executed a 35-for-34 stock split, meaning that for every 34 shares held, investors received 35 new shares.
Before the split, STX traded at 7 per share. Afterward, the share price was about 6.75.
The adjusted shares began trading on Dec 16, 2022. This was stock split number 2 in STX's history, following the previous one in Mar 1, 2021.
